Navigation Links
Einstein researchers find key gene in childhood cancer
Date:5/5/2011

May 5, 2011 (BRONX, NY) There are no effective treatments for rhabdoid tumors aggressive childhood cancers that usually strike children under three years old and affect the brain or kidneys. The disease is extremely rare fewer than 10 cases are diagnosed each year in the U.S. but is particularly difficult to treat and almost always fatal.

Now scientists at Albert Einstein College of Medicine of Yeshiva University have identified a target for potential therapies for these tumors: a gene called Aurora A that is vital for tumor growth. The research team was led by Ganjam Kalpana, Ph.D., professor of genetics and of microbiology & immunology, the Mark Trauner Faculty Scholar in Neuro-oncology at Einstein. Their findings appear in the April 26 online issue of Cancer Research.

The Aurora A gene is known to be expressed at higher-than-normal levels in many cancers, and its expression is associated with poor prognosis. Scientists have also known that mutations in a tumor suppressor gene called INI1/hSNF5 can lead to rhabdoid tumors. In this study, the Kalpana team found that, in rhabdoid tumors, loss of the tumor suppressor gene INI1/hSNF5 leads to changes in Aurora A's expression that are crucial for tumor growth.

In experiments involving rhabdoid tumors and tumor cell lines, the Einstein scientists showed for the first time that Aurora A is highly expressed in both human and mouse rhabdoid tumors, that the loss of the INI1/hSNF5 tumor suppressor gene from rhabdoid tumor cells leads to the "de-repression" of Aurora A, and that knocking down Aurora A's expression in rhabdoid tumor cells potently inhibits the growth of those cells.

"Our findings indicate that targeting Aurora A could be an effective strategy for halting rhabdoid tumor growth," said Dr. Kalpana. She notes that many Aurora A inhibitors are now being tested against several types of cancers, includingmelanoma and non-Hodgkin's lymphoma, and other researchers have now expressed interest in using Aurora A inhibitors in trials for children with rhabdoid brain tumors.


'/>"/>

Contact: Kim Newman
sciencenews@einstein.yu.edu
718-430-3101
Albert Einstein College of Medicine
Source:Eurekalert

Related biology news :

1. Albert Einstein College of Medicine geneticist wins Sloan Research Fellowship
2. Einstein researcher receives American Cancer Society Medal of Honor
3. Einstein receives $30 million to study protein form and function
4. Einstein designated an NIH Center of Excellence for aging research
5. Einstein receives $4 million to test HPV microbicide
6. Einstein researcher awarded prestigious cancer research grant
7. Einstein-Montefiore research tackles childhood obesity in the Bronx
8. Einstein researchers discover 2 new ways to kill TB
9. Einstein receives high-risk/high-reward cancer research funding
10. Einstein to develop anti-HIV drug delivery system
11. Einstein scientists move closer to a safer anthrax vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 /PRNewswire/ ... product subsidiary of Infosys (NYSE: INFY ), and ... global partnership that will provide end customers with ... banking and payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ... area for financial services, but it also plays a fundamental ...
(Date:4/26/2016)... and LONDON , ... Finacle, part of EdgeVerve Systems, a product subsidiary ... Onegini today announced a partnership to integrate the ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... provide their customers enhanced security to access and ...
(Date:4/19/2016)... April 20, 2016 The new ... a compact web-based "all-in-one" system solution for all door ... reader or the door interface with integration authorization management ... control systems. The minimal dimensions of the access control ... the building installations offer considerable freedom of design with ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... on quality, regulatory and technical consulting, provides a free webinar on ... on July 13, 2016 at 12pm CT at no charge. , Incomplete investigations ...
(Date:6/23/2016)... PUNE, India , June 23, 2016 /PRNewswire/ ... culture media market research report to its pharmaceuticals ... company profiles, product details and much more. ... market spread across 151 pages, profiling 15 companies ... now available at http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . ...
(Date:6/22/2016)... , June 22, 2016  According to ... next generation sequencing (NGS) market include significant efforts ... smaller sequencers.  More accessible and affordable sequencers, say ... growing demand for consumables including sample prep materials.  ... Market for Sample Preparation for Next Generation Sequencing ...
Breaking Biology Technology: